Status:
RECRUITING
Austrian Left Atrial Appendage Closure Registry
Lead Sponsor:
Medical University of Graz
Conditions:
Atrial Fibrillation
Left Atrial Appendage Closure
Eligibility:
All Genders
18+ years
Brief Summary
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registr...
Eligibility Criteria
Inclusion
- Patients who received LAAC in Austria
Exclusion
- Absence of informed consent
Key Trial Info
Start Date :
May 16 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03409159
Start Date
May 16 2017
End Date
December 1 2025
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria, 8036